Zacks.com on MSN19h
CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?
CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...
Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?
We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...
Super Micro Stock Is Jumping Again. Why SMCI Is on Its Best Run in Months.
The server maker's shares have climbed more than 30% over the past four days, powered higher by two bits of good news.